AU2002223593A1 - Regulation of human sphingosine kinase-like protein - Google Patents

Regulation of human sphingosine kinase-like protein

Info

Publication number
AU2002223593A1
AU2002223593A1 AU2002223593A AU2359302A AU2002223593A1 AU 2002223593 A1 AU2002223593 A1 AU 2002223593A1 AU 2002223593 A AU2002223593 A AU 2002223593A AU 2359302 A AU2359302 A AU 2359302A AU 2002223593 A1 AU2002223593 A1 AU 2002223593A1
Authority
AU
Australia
Prior art keywords
protein
regulation
sphingosine kinase
human sphingosine
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002223593A
Inventor
Jeffrey Encinas
Sophia Kossida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2002223593A1 publication Critical patent/AU2002223593A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Transplantation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2002223593A 2000-10-06 2001-10-05 Regulation of human sphingosine kinase-like protein Abandoned AU2002223593A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US23800500P 2000-10-06 2000-10-06
US60/238,005 2000-10-06
US31411301P 2001-08-23 2001-08-23
US60/314,113 2001-08-23
PCT/EP2001/011516 WO2002028906A2 (en) 2000-10-06 2001-10-05 Regulation of human sphingosine kinase-like protein

Publications (1)

Publication Number Publication Date
AU2002223593A1 true AU2002223593A1 (en) 2002-04-15

Family

ID=26931246

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002223593A Abandoned AU2002223593A1 (en) 2000-10-06 2001-10-05 Regulation of human sphingosine kinase-like protein

Country Status (5)

Country Link
US (1) US20030125533A1 (en)
EP (1) EP1326986A2 (en)
JP (1) JP2004510429A (en)
AU (1) AU2002223593A1 (en)
WO (1) WO2002028906A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2412876A1 (en) * 2000-06-14 2002-12-13 Sankyo Company Limited Ceramide kinase and dna encoding the same
US20030096022A1 (en) * 2000-12-22 2003-05-22 Medlyte, Inc. Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
EP1404364A4 (en) * 2001-06-07 2005-09-28 Medvet Science Pty Ltd Sphingosine kinase interacts with traf2 and modulates tumor necrosis factor-induced cellular activity
WO2004035786A1 (en) * 2002-10-14 2004-04-29 Medvet Science Pty. Ltd. A method of modulating epithelial cell activity by modulating the functional levels of sphingosine kinase
WO2004061107A1 (en) * 2002-12-27 2004-07-22 The New Industry Research Organization Cell growth inhibitor using sphingosine kinase 2, method of constructing fused protein having its nuclear localization signal, method of screening drug candidate, and screening kit
WO2005021754A1 (en) * 2003-08-27 2005-03-10 Genpath Pharmaceuticals, Inc. Gp131: methods and compositions for treating cancer
US7794713B2 (en) * 2004-04-07 2010-09-14 Lpath, Inc. Compositions and methods for the treatment and prevention of hyperproliferative diseases
US9274130B2 (en) 2006-05-31 2016-03-01 Lpath, Inc. Prevention and treatment of pain using antibodies to lysophosphatidic acid
US9274129B2 (en) * 2006-05-31 2016-03-01 Lpath, Inc. Methods and reagents for detecting bioactive lipids
US8796429B2 (en) * 2006-05-31 2014-08-05 Lpath, Inc. Bioactive lipid derivatives, and methods of making and using same
US9217749B2 (en) * 2006-05-31 2015-12-22 Lpath, Inc. Immune-derived moieties reactive against lysophosphatidic acid
US7862812B2 (en) 2006-05-31 2011-01-04 Lpath, Inc. Methods for decreasing immune response and treating immune conditions
US7829674B2 (en) 2006-10-27 2010-11-09 Lpath, Inc. Compositions and methods for binding sphingosine-1-phosphate
CN101687031B (en) * 2006-10-27 2014-05-14 勒帕斯公司 Compositions and methods for treating ocular diseases and conditions
US8361465B2 (en) * 2007-10-26 2013-01-29 Lpath, Inc. Use of anti-sphingosine-1-phosphate antibodies in combination with chemotherapeutic agents
US8871202B2 (en) 2008-10-24 2014-10-28 Lpath, Inc. Prevention and treatment of pain using antibodies to sphingosine-1-phosphate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000052173A2 (en) * 1999-03-02 2000-09-08 Nps Allelix Corp. Cloned human sphingosine kinase homologues
AU3828301A (en) * 2000-02-14 2001-08-27 Curagen Corp Novel sphingosine kinases
CA2412876A1 (en) * 2000-06-14 2002-12-13 Sankyo Company Limited Ceramide kinase and dna encoding the same

Also Published As

Publication number Publication date
US20030125533A1 (en) 2003-07-03
JP2004510429A (en) 2004-04-08
EP1326986A2 (en) 2003-07-16
WO2002028906A2 (en) 2002-04-11
WO2002028906A3 (en) 2002-11-14

Similar Documents

Publication Publication Date Title
AU2002223593A1 (en) Regulation of human sphingosine kinase-like protein
AU6604901A (en) Regulation of human hm74-like g protein coupled receptor
AU2001246526A1 (en) Regulation of human hm74-like g protein coupled receptor
AU2002211561A1 (en) Regulation of human skin healing
AU2001281950A1 (en) Regulation of human thimet oligopeptidase-like enzyme
AU2001274080A1 (en) Regulation of human transketolase-like enzyme
AU2002231620A1 (en) Regulation of human patched-like protein
AU2002215956A1 (en) Regulation of human pgc-1-like protein
AU2002237225A1 (en) Regulation of human patched-like protein
AU2002247691A1 (en) Regulation of human elongase hselo1-like protein
AU2001293780A1 (en) Regulation of human protein phosphatase iic-like enzyme
AU2001262133A1 (en) Regulation of human nedd1-related protein
AU2002218196A1 (en) Regulation of human adam-ts-like protein
AU2002219083A1 (en) Regulation of human oat-like protein
AU2002219046A1 (en) Regulation of human ceruloplasmin-like protein
AU2001263814A1 (en) Regulation of human oatp2-related protein
AU2002233201A1 (en) Regulation of human tyrosine phosphatase
AU2002215942A1 (en) Regulation of human carboxylesterase-like enzyme
AU2001285782A1 (en) Regulation of human phosphodiesterase-like enzyme
AU2002210525A1 (en) Regulation of human phospholipase-like enzyme
AU2001281969A1 (en) Regulation of human carboxylesterase-like enzyme
AU2002220630A1 (en) Regulation of human serine-threonine protein kinase
AU2002250900A1 (en) Regulation of human elongase hselo1-like protein
AU2002217134A1 (en) Regulation of human protein l-isoaspartate o-methyltransferase-like enzyme
AU2001254740A1 (en) Regulation of human tap-related protein